You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

DYCILL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dycill patents expire, and what generic alternatives are available?

Dycill is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in DYCILL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dycill

A generic version of DYCILL was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DYCILL?
  • What are the global sales for DYCILL?
  • What is Average Wholesale Price for DYCILL?
Summary for DYCILL
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 54
Patent Applications: 1,021
DailyMed Link:DYCILL at DailyMed
Drug patent expirations by year for DYCILL

US Patents and Regulatory Information for DYCILL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 060254-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 062238-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 062238-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 060254-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.